baber/WOPTO huggingface dataset:
Patent DE-69922684-T2 (DE)
Inventor: GREEN J
IPC: A61K31/56
Filed: 1999-08-10
Granted: 2005-10-06
Abstract: The present invention provides compounds that are useful for inhibiting the proliferation of fungi. The compounds are estrogenic derivatives, such as 2ME2, or anti-estrogenic compounds. The compounds may be used for treating infections of fungi in humans and animals, or to prevent or inhibit the growth of fungi on any surface.
Patent DE-69923016-T2 (DE)
Inventor: HOJEIBANE HIKMAT
IPC: A61F2/06
Filed: 1999-02-23
Granted: 2005-12-01
Abstract: A stent with axial flexibility, in a preferred embodiment, has a longitudinal axis and comprises a plurality of longitudinally disposed bands, wherein each band defines a generally continuous wave along a line segment parallel to the longitudinal axis. A plurality of links maintains the bands in a tubular structure. In a further embodiment of the invention, each longitudinally disposed band of the stent is connected, at a plurality of periodic locations, by a short circumferential link to an adjacent band. Further, a pair of bifurcated stents is disclosed.
Patent DE-69926537-T2 (DE)
Inventor: HEALY LU
IPC: A61Q17/04
Filed: 1999-10-25
Granted: 2006-06-08
Abstract: <P>PROBLEM TO BE SOLVED: To provide gelled ester compositions which are gel compositions containing esters, ethers, alcohols, naturally-occurring fats and oils, or mixtures thereof.  <P>SOLUTION: The gelled esters are obtained by mixing a suitable ester with one or more triblock copolymers, star polymers, radial polymers, multi-block copolymers, or mixtures thereof. Optionally, one or more diblock copolymers can be used in forming the gel compositions. In addition to gelled esters, gelled alcohols, gelled ethers, and gelled naturally-occurring fats and oils also are obtained by using one or more diblock copolymers, triblock copolymers, star polymers, radial polymers, multi-block copolymers, or mixtures thereof as a gelling agent. Butyl rubbers and alkyl galactomannan also can be used as a gelling agent. The gel compositions may be used to suspend various solids and/or liquids.  <P>COPYRIGHT: (C)2010,JPO&INPIT
Patent DE-69928120-T2 (DE)
Inventor: VAN SWIETEN PETRUS
IPC: C08F20/18
Filed: 1999-07-30
Granted: 2006-07-20
Abstract: Process for providing acrylic (co)polymers suitable for high solids coating applications, comprising the step of: contacting under polymerizing conditions, the asymmetric, saturated peroxide compound tertiary-butyl-1,1,3,3 tetramethylbutyl peroxide (TBTMBP) with a polymerizable acrylate monomer, in which process the acrylate monomer is selected from the group consisting essentially of: hydroxyalkyl acrylates and methacrylates including 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxybutyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, 2 hydroxybutyl methacrylate, 3 hydroxypropylacrylate, 4-hydroxybutylacrylate; alkyl acrylate and methacrylates including methyl methacrylate, ethyl methacrylate, butyl methacrylate, isobutyl methacrylate, hexyl methacrylate, 2-ethylhexyl methacrylate, lauryl methacrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, butyl acrylate, isobutyl acrylate, hexyl acrylate, 2-ethylhexyl acrylate, lauryl acrylate, and styrene, para-methyl styrene, acrylic acid, methaccrylic acid, or vinyl acetate.
Patent DE-69934505-T2 (DE)
Inventor: SHIMIZU TOSHIHIRO
IPC: A61K9/26
Filed: 1999-05-17
Granted: 2007-10-04
Abstract: An orally disintegrable tablet, of the present invention, which comprises (i) fine granules having an average particle diameter of 400 mu m or less, which fine granules comprise a composition coated by an enteric coating layer, said composition having 10 weight % or more of an acid-labile physiologically active substance and (ii) an additive, has superior disintegrability or dissolution in the oral cavity so that it can be used for treatment or prevention of various diseases, as an orally disintegrable tablet capable of being administered to the aged or children and easily administered without water. Also, because the tablet of the present invention contains fine granules having the average particle diameter such that it will not impart roughness in mouth, it can be administered easily without discomfort at the administration.
Patent DE-69937351-T2 (DE)
Inventor: DICKASON DAVID A
IPC: A61K47/10
Filed: 1999-08-06
Granted: 2008-07-17
Abstract: A non-aqueous, particle-forming, fused pyrrolocarbazole-containing composition is disclosed. Upon contact with an aqueous medium, the particle-forming composition spontaneously disperses into suspended particles, thereby forming a stable suspension that provides greatly improved bioavailability of orally administered fused pyrrolocarbazole compounds.
Patent TR-200003070-T2 (TR)
Title: Bir komonomer olarak izosorbit içeren polyesterler
Inventor: KHANARIAN GARO
IPC: C08L71/00
Filed: 1999-04-22
Abstract: Bir polyester ve diger bir termoplastik polimeri içine alan bir polimer karisimi. Polyester, tereftaloil parçalarini ve istege bagli olarak, diger aromatik diasit parçalarini; ve etilen glikol parçalarini; istege bagli olarak dietilen glikol parçalarini; izosorbit parçalarini; ve istege bagli olarak bir ya da daha fazla diger diol parçalarini içine alir. Polyester, en az yaklasik olarak 0.35 dL/g'lik dogal bir viskoziteye sahiptir.
Patent TR-200003779-T2 (TR)
Title: Transkripsiyon faktörü NF-kB inhibitörleri
Inventor: CALLAHAN JAMES FRANCIS
IPC: A61K31/4453
Filed: 1999-06-18
Abstract: Bu bulus, trankripsiyon faktörü NF-kB nin farmasötik olarak kabul edilebilir tuzlari, hidratlari ve solventlerinin amino-indanon inhibitörlerini, bu bilesimlerin terkiplerini ve NF-kB aktivasyonunun rol  oyandigi hastaliklari tedavi yöntemleri saglamaktadir. Bu bulus özellikle örnegin enflamatuar hastaliklarin, özellikle romatizmal artrit, enflamatuar barsak hastaligi, ve astim; sedef hastaligi ve atopik dermatil dahil, dermatoz; oto-immün hastaliklar; doku ve organ reddi; alzheimer hastaligi; felç; ateroskleroz; restenoz; kanser ve Hodojken hastaligi; bazi viral enfeksiyonlar, AIDS dahil; osteoartrit; osteoporoz; ve Ataxia Telangiestasia gibi  NF-kB aktivasyonuyla baglantili çesitli hastaliklarin, ihtiyaci olan hastaya bir bulus bilesimi  verilmesi için yöntemler saglar.
Patent TR-200100284-T2 (TR)
Title: Bazla ateşlenen tahliye mikrokapsülleri.
Inventor: KOPPENHAGEN JUANITA E VAN
IPC: A01N25/28
Filed: 1999-07-28
Abstract: Bir aminoplast kabuk cidarindan ve cidar içerisinde kapsüllenmis olarak bulunan madde  ya da maddelerden olusturulmus olan mikro kapsüller, ki cidar bazla parçalanabilen bir ester kismi içerir. Bu kapsüllerin ortamda baz bulunmasina karsi çok duyarli olduklari bulunmustur, kapsül cidarlari kapsüllenmis olan maddelerin süratle serbest birakilmalarini saglayacak sekilde nispeten hizla ayrilmakta ya da parçalanmaktadir.
Patent TR-200200163-T2 (TR)
Inventor: FISCHER WALTER
IPC: C07C319/12
Filed: 2000-07-20
Abstract: Compounds of formula Ia or Ib wherein A is an (n+1)-valent aliphatic, cycloaliphatic, araliphatic or aromatic radical and n is an integer from 0 to 5, E is an (m+1)-valent aliphatic, cycloaliphatic, araliphatic or aromatic radical and m is an integer from 0 to 3, X is -O-, -C(-O)O or -CHR<SUB>4</SUB>-, with R<SUB>4 </SUB>and R<SUB>3 </SUB>together forming an ethylene group, R<SUB>1 </SUB>and R<SUB>2 </SUB>are, each independently of the other, hydrogen or methyl, R<SUB>3 </SUB>is hydrogen, or R<SUB>3 </SUB>and R<SUB>4 </SUB>together form an ethylene group, and R<SUB>5 </SUB>is a monovalent aliphatic, cycloaliphatic, araliphatic or aromatic radical, are highly reactive curing agents for epoxy resins and yield cured products having improved resistance to chemicals.
Patent TR-200503532-T2 (TR)
Title: Erukamid içermeyen kapak ve astar kompozisyonları.
Inventor: COUTURIER MARYSUSAN
IPC: C08K5/20
Filed: 2004-02-26
Abstract: Kap kapakları veya kapak dolgu malzemeleri yapılması amaçlı, erukamid içermeyen örnek bir kompozisyon, bir matris polimer; poli(dimetil) siloksan gibi bir silikon yağlayıcı; ve doymuş bir amid, oksidize edilmiş polietilen veya bunların kombinasyonunu içeren bir kaydırma yardımcısı içerir.
Patent TR-201005282-T2 (TR)
Title: Sübstitüe edilmiş 2-(2,b-dioksopiperidin-3-il)-ftalimidler ve -1-oksoizoindolinler ve TNF alfa seviyelerini düşürmek için yöntem.
Inventor: MULLER GEORGE W
IPC: A61P31/06
Filed: 1998-05-28
Abstract: Sübstitüe edilmiş 2-(2,6-diokzopiperidın-3-ıl)-ftalimidler ve 1-okzo-2-{2,6-dıokzopıpendın-3-ıl)izoindolinler, bir memelide TNFalfa seviyelerini düşürürler. Tipik bir şık, 1-okzo-2-( ,6-dıokzo- -metılpiperidın-3-il)-4,5,6,7-tetrafloroizoindolindır.
Patent DE-602005000086-T2 (DE)
Inventor: KOBAYASHI SHINICHIRO
IPC: A61B19/02
Filed: 2005-06-04
Granted: 2007-04-12
Abstract: The present invention is to provide a package from which a piece of the contents is easily taken out. This package (100) is constituted of a film (110) comprising a soft packaging material, on the surface of which a cut line (111) is provided, such that, inside the cut line (111), an openable region (150) is formed for taking contents out from the package (100). Further, inside an openable region (150), dashed lines (112) are provided, and when the a lid member (120) adhering to cover the openable region (150) is peeled, the openable region (150) easily adheres to the lid member (120) side owing to the dashed lines (112), such that the opened portion is reliably formed.
Patent DE-602005002448-T2 (DE)
Inventor: LAROCHE GEORGES
IPC: F04B49/24
Filed: 2005-12-14
Granted: 2008-06-12
Abstract: The device has a tank (1) that receives a construction material to be projected under form of a mixture and communicates with a pump (11) which is actuated by a motor (7) through a reducing gear (8). A material routing tube (13) is connected in a pump outlet using the component that permits to couple and decouple the tube. A return tube (12) is connected in the outlet and is mounted in closed circuit on the tank.
Patent DE-602005003047-T2 (DE)
Inventor: NAKAGAWA OSAMU
IPC: C08K5/00
Filed: 2005-03-11
Granted: 2008-08-14
Abstract: A laser-transmissible composition comprises:  a dynamic crosslinking polyolefin thermoplastic elastomer that has a melting point ranging from 160 to 210 degrees Centigrade in case of non-coloring, and dye salt exhibiting transmission of a laser having a wavelength of 800 to 1200 nm.  <??>A method for laser welding comprises:  putting a laser-transmissible molded workpiece 1 made from the laser-transmissible composition onto a laser-absorptive molded workpiece 2 having a laser-absorbent 7, irradiating laser 3 towards the laser-transmissible molded workpiece 1 to weld the laser-transmissible molded workpiece 1 and the laser-absorptive molded workpiece 2.  <IMAGE>
Patent DE-602005005769-T2 (DE)
Inventor: MIYAGI IWAO
IPC: B41F33/00
Filed: 2005-12-12
Granted: 2009-05-07
Abstract: A printing press includes a dampening device (2), inking device (3), and fan roller (21,41,51). The dampening device (2) efficiently supplies dampening water to a plate mounted on a plate cylinder. The inking device (3) supplies ink to the plate mounted on the plate cylinder through an ink roller group (9). The fan roller (21,41,51) is arranged in the vicinity of the ink roller group (9) and driven to rotate. The fan roller (21,41,51) includes a pair of opposing wheels (22), an air intake port (26), and a plurality of vane members (27,42). The air intake port (26) is formed in at least one of the wheels (22). The first vane members (27) each have two ends fixed to the pair of wheels (22), and discharge air, taken in through the air intake port (26), in a radial direction of the fan roller (21,41,51) as the fan roller (21,41,51) rotates.
Patent DE-69903799-T3 (DE)
Inventor: VAN DALEN FRANS
IPC: C07C235/30
Filed: 1999-03-05
Granted: 2006-11-16
Abstract: Process for the preparation of a compound of formula (VI), comprising the steps of: reacting a compound of general formula (I) with a ring-opening agent to provide a compound having general formula (II); protecting the hydroxy groups of the thus formed compound (II) with a pre-determined protective agent in order to substantially retard the reactivity thereof and provide a compound having general formula (III) or (VII), wherein the protective agent retards the reactivity of compound (II) by replacing the hydrogen atom of at least one of the hydroxy groups thereof with a carbon terminated group, whereby, in the case of compound (III) at least one of R<3> and R<4> is not hydrogen; reacting compound (III) and/or (VII) with an alkylating agent of formula R<7>X to obtain a compound having formula (IV) or (VIII) respectively, wherein R<7> preferably represents a methyl or ethyl group and X represents a halide, preferably chlorine, bromine or iodine; hydrolyzing the protective groups R<3>, R<4> and R<5>, R<6> of compounds (IV) and (VIII) respectively to obtain a compound of formula (V); relactonizing compound (V) to yield compound (VI).
Patent DK-1179560-T3 (DK)
Inventor: SOEHNEN DIETMAR DR
IPC: C08L91/02
Filed: 2000-07-24
Granted: 2003-07-28
Abstract: A sulfur crosslinkable rubber mixture devoid of aromatic process oil containing at least one diene elastomer as filler and at least finely divided silicic acid and carbon black, a plasticizer, a silane coupling agent, and other conventional additives is new. A sulfur crosslinkable rubber mixture devoid of aromatic process oil contains at least one diene elastomer as filler and at least finely divided silicic acid and carbon black, a plasticizer, a silane coupling agent, and other conventional additives. The plasticizer comprises 5-60 phr (wt.% relative to the 100 wt.% of total rubber mixture) of at least one mineral oil plasticizer, containing less than 3 wt.% of polycyclic aromatic compounds, as determined by dimethylsulfoxide extraction in accordance with the IP 346 method, and having a glass transition temperature below -45 degrees C, and 1-20 phr of at least one glyceride and/or factice (rubber substitute). The weight ratio of the finely divided silicic acid to the carbon black in the rubber mixture is 1:2 to 20:1. Independent claims are included for: (1) preparation of the rubber mixture by (a) mixing at least one diene elastomer, precipitated silicic acid, carbon black at least one mineral oil plasticizer, and at least one glyceride and/or a factice, at least one silane coupling agent , and conventional additives, without the vulcanization system with simultaneous heating of the composition up to 180 degrees C, and (b) mixing in of the vulcanization system at a temperature below the vulcanization temperature, and subjection of the mixture obtained to consecutive heating and cooling cycles; (2) a rubber product, especially tire treads (sic) containing a sulfur vulcanized rubber mixture as defined above; (3) tires containing tire treads (sic) obtained at least partially from the sulfur vulcanized rubber mixture defined above.
Patent DK-1085019-T3 (DK)
Inventor: HAMIED YUSUF KHWAJA DR
IPC: C07D401/12
Filed: 2000-09-07
Granted: 2003-05-26
Abstract: Omeprazole (VI) is made by the route:  <CHEM>
Patent DK-1187669-T3 (DK)
Inventor: MATACOTTA FRANCESCO CINO
IPC: B01J37/02
Filed: 2000-06-06
Granted: 2004-05-03
Abstract: A catalyst for the full oxidation of volatile organic compounds (VOC), particularly hydrocarbons, and of CO to CO2, comprising:a non-stoichiometric crystalline compound conventionally designated by a formula which corresponds to A14Cu24O41 (I), where A is Sr or a solid solution of Sr with alkaline-earth metals, alkaline metals, lanthanides; or a non-stoichiometric crystalline compound conventionally designated by a formula which corresponds to B4Cu5O10 (II), where B is Ca or a solid solution of Ca with alkaline-earth metals, alkaline metals, lanthanides; or mixtures thereof; and in that it is prepared in a form which has a large specific surface area, preferably larger than 25 m<2>/g;a method for preparing the catalysts; their use in methods for the full oxidation of VOC and of CO to CO2; and the oxidation methods.
Patent DK-1189553-T3 (DK)
Inventor: STRATFORD PETER WILLIAM
IPC: A61F2/91
Filed: 2000-06-26
Granted: 2004-07-26
Abstract: The present invention relates to a balloon expandable stent mounted on a balloon catheter, the entire assembly being overcoated with a coherent polymer coating, which is preferably substantially continuous over the circumference and, more preferably, axial length of the stem on the balloon. The polymer coating improves retention of the stent on the balloon during delivery and does not adversely effect the deployment characteristics, nor the balloon failure characteristics. The product is made by mounting the stent on the balloon and coating the assembly with a liquid coating composition containing a suitable polymer followed by curing of the coating. The polymer is biocompatible and preferably crosslinkable in the coating composition, and crosslinked in the final product. A suitable polymer is formed from monomers including a zwitterionic, preferably a phosphoryl choline, group, and monomers including a trialkoxysilyl group. Preferably the coated product is contacted with ethylene oxide to provide simultaneous sterilization and additional curing.
Patent DK-1214309-T3 (DK)
Inventor: CAZAUX JEAN-BERNARD
IPC: C07D311/66
Filed: 2000-09-01
Granted: 2004-07-12
Abstract: New intermediates of the formula (II)B described below for the synthesis of amidine derivatives of (-)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid, such as for example (S)-N-{4-[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)-carbonyl]-1-piperazinyl]phenyl}-2-thiophenecarboximidamidewherein A' isX is -Z1-CO;rho is a bond or a heterocycle selected from the group consisting of piperidine, piperazine, homopiperazine, 2-methylpiperazine, 2,5-dimethyl-piperazine and 4-aminopiperidine;Y is -Z2- or -NR3-Z2,R3 is hydrogen, alkyl of 1 to 6 carbon atoms or -COR4,R4 is alkyl of 1 to 6 carbon atoms;Z1 and Z2 independently are a single bond or alkylene of 1 to 6 carbon atoms;and R6 is hydrogen or OH.
Patent DK-1266058-T3 (DK)
Inventor: ORLANDI VITTORIO
IPC: D04H1/26
Filed: 2001-01-13
Granted: 2005-02-14
Abstract: Method of producing a composite nonwoven for receiving and storing liquids or the like, comprising a carded nonwoven, which is treated in order to consolidate it, and a pulp layer, such as a wood pulp fiber layer, applied to the consolidated carded nonwoven and brought into secure contact with same, characterised in that the carded nonwoven is consolidated dry before being coated with the super-absorbent material, then the layer formed from the pulp fibers is applied to this pre-consolidated carded nonwoven and everything is interconnected.
Patent DK-1273322-T3 (DK)
Inventor: LUEDERS BRUNO
IPC: A62C35/58
Filed: 2002-05-17
Granted: 2010-10-04
Abstract: The method involves measuring a space or a room with a distance measuring device arranged in the space or room and determining the distance between the walls in different spatial directions. A virtual 3D model of the room is then produced in a computer. An extinguishing area (11) is defined in the 3D model. At least one activation criterium for the extinguishing system is determined. The start point for an extinguisher line (28) is also determined. The locations of extinguisher jets or nozzles (27) are determined by the computer. According to the criteria, the extinguisher configuration is automatically constructed in the 3D model to provide a 3D model of the extinguisher line configuration. Independent claims also cover an apparatus for carrying out the method.
Patent DK-1350796-T3 (DK)
Inventor: CROOKE HELEN RACHEL
IPC: A61K39/102
Filed: 2002-04-05
Granted: 2009-03-02
Abstract: A mutant of a Gram negative bacterium, wherein said bacterium has a mutation in a nucleotide sequence which codes for a polypeptide having an identity which is equal or more than 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% with an amino acid sequence coded by a nucleotide sequence selected from the group consisting of nucleotide sequences identified SEQ ID NO: 2, 6, 9, 12, 16, 19, 22, 25, 28, 31, 34, 37, 40, 43, 46, 49, 52, 55, 58, 61, 64, 67, 70, 75, 78, 81, 84, 87, 90 said mutation resulting in attenuated virulence of the bacterium, Immunogenic compositions and vaccines containing such a mutant.
Patent DK-1378040-T3 (DK)
Inventor: LAMMERS AREND JAN WILLEM
IPC: H01H33/22
Filed: 2002-04-09
Granted: 2007-04-16
Abstract: Single phase or polyphase switchgear having one or more switches which are mounted with the aid of solid insulation such that they are insulated, as well as associated live components such as rail systems, connectors and the like. Both the switches and the associated live components are housed in a housing enveloping the switches and live components. The enveloping housing is filled with air having a low moisture content and the interior space thereof is sealed with respect to the exterior space around the enveloping housing in such a way that the air present in the housing is not contaminated and will not reach the dew point.
Patent DK-1373300-T3 (DK)
Inventor: SELVE NORMA
IPC: A61K38/00
Filed: 2002-03-19
Granted: 2009-08-31
Abstract: The present invention concerns the use of compounds of the Formula (I): <CHEM> for treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary inflammatory osteoarthritic pain. The compounds show an antinociceptive profile and differ from classical analgesics like opioids and non-steroidal anti-inflammatory drugs (NSAIDS) and are useful as specific analgesics.
Patent DK-1409365-T3 (DK)
Inventor: CECCHINI MARCO
IPC: A61M15/00
Filed: 2002-07-24
Granted: 2006-02-20
Abstract: The present invention relates to a cartridge for medicinal dry powder inhalers, defined as "autoperforating" because it is able to hold a perforating mechanism that  consequently activates the function of spreading its content into the passage of an inhaler until the content is ready for being subsequently inhaled.  The autoperforating cartridge consists of one blister, with rigid basal structure, combined with one lining made of  proper material to be easily broken by a frame preferably plastic. The manual pressing on the back convexity of the cartridge causes the breaking of the basal lining of the cartridge itself and sets the medicinal ready for being inhaled by a delivering-item less or more complex. The  present cartridge is particularly fit for being placed on a single-use inhaler.  '
Patent DK-1547664-T3 (DK)
Inventor: RAMOS DE LA FUENTE RUBEN
IPC: F24F8/133
Filed: 2002-09-20
Granted: 2011-08-15
Abstract: A system and a apparatus for mass transfer from liquid phase to gaseous phase with pollutant removal is describe, they comprise a plurality of cells 31 for liquid membrane generation wherein the liquid membranes collapse upon contact with a gaseous stream, the collapsed liquid material covers up the suspended particles, and removes them by decantation, and wherein the membrane cells 31 increase the speed of the gaseous stream, and make it collide at 45 DEG  on the liquid surface, thereby the transfer of vapor into the gas is improved. <IMAGE>
Patent DK-1569929-T3 (DK)
Inventor: NGUYEN-BA NGHE
IPC: A61K31/4025
Filed: 2003-12-09
Granted: 2010-08-16
Abstract: The present invention provides novel compounds represented by formula (I) or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
Patent DK-1572959-T3 (DK)
Inventor: VANDER HORN PETER
IPC: C12N15/10
Filed: 2003-07-25
Granted: 2011-02-07
Abstract: This invention relates to methods for the facilitated evolution of proteins. The invention provides methods for generating hybrid proteins and improved proteins obtained using the methods.